Implantica AG
Implantica AG engages in the research and distribution of medical implants in Switzerland. The company's lead product candidate is RefluxStop, a passive CE-marked implant for prevention of gastroesophageal reflux disease. It focuses on two treatment areas, Gastrointestinal surgery and Urology. It is also involved in the development of eHealth platform, a digital health system to support its pipel… Read more
Implantica AG (8IM1) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, Implantica AG (8IM1) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Implantica AG - Net Assets Trend (None–None)
This chart illustrates how Implantica AG's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Implantica AG (None–None)
The table below shows the annual net assets of Implantica AG from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to Implantica AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
Implantica AG Competitors by Market Cap
The table below lists competitors of Implantica AG ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Micropolis Holding Company
NYSE MKT:MCRP
|
$31.46 Million |
|
Bali Bintang Sejahtera Tbk PT
JK:BOLA
|
$31.48 Million |
|
CSU Digital S.A.
SA:CSUD3
|
$31.48 Million |
|
San Neng Group Holdings Co Ltd
TW:6671
|
$31.49 Million |
|
My Humble House Hospitality Management Consulting Co Ltd
TW:2739
|
$31.43 Million |
|
Volt Lithium Corp.
OTCQB:VLTLF
|
$31.43 Million |
|
Schoolblazer Limited
AU:SBZ
|
$31.42 Million |
|
Rich Sparkle Holdings Limited Ordinary Shares
NASDAQ:ANPA
|
$31.42 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Implantica AG's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares Implantica AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Implantica AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares Implantica AG's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $253,026,393
- Average return on equity (ROE) among peers: -74.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Implantica AG (8IM1) | €- | N/A | N/A | $31.45 Million |
| HeraMED Limited (1I4) | $-105.98K | 0.00% | 0.00x | $18.56 Million |
| Q-linea AB (publ) (3F80) | $163.19 Million | -164.65% | 0.41x | $9.44 Million |
| Guerbet SA (4G8) | $342.14 Million | 13.51% | 1.79x | $44.18 Million |
| Scandinavian Real Heart AB (Publ) (7820) | $111.29 Million | -9.42% | 0.06x | $4.94 Million |
| aap Implantate AG (AAQ1) | $54.78 Million | 26.71% | 0.17x | $9.65 Million |
| Carmat SA (CXT) | $7.48 Million | -557.76% | 3.92x | $1.62 Million |
| elexxion AG (E8X) | $-0.01 | 0.00% | 0.00x | $199.10K |
| AETHLON MEDIC.NEW DL-001 (EJU) | $15.06 Million | -79.86% | 0.16x | $446.12K |
| Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) | $139.44 Million | 15.79% | 0.97x | $615.93 Million |
| Gaush Meditech Ltd (F7Y) | $1.70 Billion | 10.23% | 0.68x | $29.29 Million |